Published in Int J Cancer on May 29, 1997
My Lifestyle Intervention of Food and Exercise (MyLIFE) | NCT01630499
A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes. Br J Cancer (2002) 4.18
Variation of breast cancer risk among BRCA1/2 carriers. JAMA (2008) 3.30
How many more breast cancer predisposition genes are there? Breast Cancer Res (1999) 3.10
Risk factors for breast cancer for women aged 40 to 49 years: a systematic review and meta-analysis. Ann Intern Med (2012) 2.85
Cancer as a complex phenotype: pattern of cancer distribution within and beyond the nuclear family. PLoS Med (2004) 2.67
Developing Family Healthware, a family history screening tool to prevent common chronic diseases. Prev Chronic Dis (2008) 2.20
Radiation and breast cancer: a review of current evidence. Breast Cancer Res (2004) 2.12
Increased cancer risks for relatives of very early-onset breast cancer cases with and without BRCA1 and BRCA2 mutations. Br J Cancer (2010) 1.65
The potential value of sibling controls compared with population controls for association studies of lifestyle-related risk factors: an example from the Breast Cancer Family Registry. Int J Epidemiol (2011) 1.56
Breast cancer risk prediction and individualised screening based on common genetic variation and breast density measurement. Breast Cancer Res (2012) 1.47
Sibling risks in cancer: clues to recessive or X-linked genes? Br J Cancer (2001) 1.44
Are the so-called low penetrance breast cancer genes, ATM, BRIP1, PALB2 and CHEK2, high risk for women with strong family histories? Breast Cancer Res (2008) 1.44
Using family history information to promote healthy lifestyles and prevent diseases; a discussion of the evidence. BMC Public Health (2010) 1.42
Rating the risk factors for breast cancer. Ann Surg (2003) 1.35
After BRCA1 and BRCA2-what next? Multifactorial segregation analyses of three-generation, population-based Australian families affected by female breast cancer. Am J Hum Genet (2000) 1.34
The impact of genetic counselling about breast cancer risk on women's risk perceptions and levels of distress. Br J Cancer (1999) 1.32
Quantifying the underestimation of relative risks from genome-wide association studies. PLoS Genet (2011) 1.30
Risk factors for breast cancer in Iran: a case-control study. Breast Cancer Res (2002) 1.27
Breast and colorectal cancer risk communication approaches with low-income African-American and Hispanic women: implications for healthcare providers. J Natl Med Assoc (2004) 1.19
Genetic testing: a conceptual exploration. J Med Ethics (1999) 1.17
Smoking interacts with genetic risk factors in the development of rheumatoid arthritis among older Caucasian women. Ann Rheum Dis (2006) 1.16
The contribution of genetic variants to disease depends on the ruler. Nat Rev Genet (2014) 1.16
Family history of breast cancer in first-degree relatives and triple-negative breast cancer risk. Breast Cancer Res Treat (2010) 1.14
Combined associations of genetic and environmental risk factors: implications for prevention of breast cancer. J Natl Cancer Inst (2014) 1.14
Risk of asynchronous contralateral breast cancer in noncarriers of BRCA1 and BRCA2 mutations with a family history of breast cancer: a report from the Women's Environmental Cancer and Radiation Epidemiology Study. J Clin Oncol (2012) 1.13
Increased risk of lung cancer in individuals with a family history of the disease: a pooled analysis from the International Lung Cancer Consortium. Eur J Cancer (2012) 1.07
Heritable breast cancer in twins. Br J Cancer (2002) 1.05
Predictors of participation in clinical and psychosocial follow-up of the kConFab breast cancer family cohort. Fam Cancer (2005) 1.04
Cancer incidence in relatives of a population-based set of cases of early-onset breast cancer with a known BRCA1 and BRCA2 mutation status. Breast Cancer Res (2003) 1.03
Mammographic surveillance in women aged 35-39 at enhanced familial risk of breast cancer (FH02). Fam Cancer (2014) 1.02
Can the breast screening appointment be used to provide risk assessment and prevention advice? Breast Cancer Res (2015) 1.01
Population-based estimates of the relation between breast cancer risk, tumor subtype, and family history. Breast Cancer Res Treat (2008) 1.00
Evaluating breast cancer risk projections for Hispanic women. Breast Cancer Res Treat (2011) 0.99
Urinary estrogen metabolites in women at high risk for breast cancer. Carcinogenesis (2009) 0.98
Intergenerational continuity in oral health: a review. Community Dent Oral Epidemiol (2010) 0.97
The effects of interaction between familial and reproductive factors on breast cancer risk: a combined analysis of seven case-control studies. Br J Cancer (1998) 0.94
Cancer risk in close relatives of women with early-onset breast cancer--a population-based incidence study. Br J Cancer (1999) 0.94
Factors Associated With Rates of False-Positive and False-Negative Results From Digital Mammography Screening: An Analysis of Registry Data. Ann Intern Med (2016) 0.94
Self-reported chemicals exposure, beliefs about disease causation, and risk of breast cancer in the Cape Cod Breast Cancer and Environment Study: a case-control study. Environ Health (2010) 0.93
Perceived familiarity with and importance of family health history among a medically underserved population. J Community Genet (2012) 0.91
Influence of perceived breast cancer risk on screening behaviors of female relatives from the Ontario site of the Breast Cancer Family Registry. Eur J Cancer Prev (2011) 0.91
Development and validation of risk prediction algorithms to estimate future risk of common cancers in men and women: prospective cohort study. BMJ Open (2015) 0.91
Family history, and impact on clinical presentation and prognosis, in a population-based breast cancer cohort from the Stockholm County. Fam Cancer (2006) 0.90
Health behaviors and cancer screening among Californians with a family history of cancer. Genet Med (2012) 0.89
Family history of breast cancer and all-cause mortality after breast cancer diagnosis in the Breast Cancer Family Registry. Breast Cancer Res Treat (2008) 0.88
Genome-wide association study of breast cancer in the Japanese population. PLoS One (2013) 0.87
Mammography Decision Aid Reduces Decisional Conflict for Women in Their Forties Considering Screening. J Womens Health (Larchmt) (2015) 0.87
Evaluation of the Families SHARE workbook: an educational tool outlining disease risk and healthy guidelines to reduce risk of heart disease, diabetes, breast cancer and colorectal cancer. BMC Public Health (2015) 0.87
Adherence to breast and ovarian cancer screening recommendations for female relatives from the Ontario site of the Breast Cancer Family Registry. Eur J Cancer Prev (2011) 0.87
Familial and perceived risk of breast cancer in relation to use of complementary medicine. Cancer Epidemiol Biomarkers Prev (2008) 0.87
Race and family history assessment for breast cancer. J Gen Intern Med (2005) 0.87
Cohort Profile: The Breast Cancer Prospective Family Study Cohort (ProF-SC). Int J Epidemiol (2015) 0.87
Family history of malignancies and risk of breast cancer: prospective data from the Shanghai women's health study. Cancer Causes Control (2008) 0.87
Preliminary evaluation of the publicly available Laboratory for Breast Radiodensity Assessment (LIBRA) software tool: comparison of fully automated area and volumetric density measures in a case-control study with digital mammography. Breast Cancer Res (2015) 0.87
Identification of new genetic susceptibility loci for breast cancer through consideration of gene-environment interactions. Genet Epidemiol (2013) 0.86
Interactions between genes involved in the antioxidant defence system and breast cancer risk. Br J Cancer (2006) 0.86
Mapping of three genetic determinants of susceptibility to estrogen-induced mammary cancer within the Emca8 locus on rat chromosome 5. Cancer Prev Res (Phila) (2012) 0.85
Validation of family cancer history data in high-risk families: the influence of cancer site, ethnicity, kinship degree, and multiple family reporters. Am J Epidemiol (2015) 0.84
Family history and oral health: findings from the Dunedin Study. Community Dent Oral Epidemiol (2011) 0.84
Polymorphisms of TP53 codon 72 with breast carcinoma risk: evidence from 12226 cases and 10782 controls. J Exp Clin Cancer Res (2009) 0.84
Gene-environment interaction and risk of breast cancer. Br J Cancer (2016) 0.83
A family history of breast cancer will not predict female early onset breast cancer in a population-based setting. BMC Cancer (2008) 0.83
The relationship between knowledge of family history and cancer characteristics at diagnosis in women newly-diagnosed with invasive breast cancer. Fam Cancer (2009) 0.83
Estimates of heritable and environmental components of familial breast cancer using family history information. Br J Cancer (2007) 0.82
Association between body mass index and risk of breast cancer among females of north India. South Asian J Cancer (2013) 0.82
Contribution of the Defective BRCA1, BRCA2 and CHEK2 Genes to the Familial Aggregation of Breast Cancer: a Simulation Study Based on the Swedish Family-Cancer Database. Hered Cancer Clin Pract (2004) 0.82
Family history of later-onset breast cancer, breast healthy behavior and invasive breast cancer among postmenopausal women: a cohort study. Breast Cancer Res (2010) 0.81
Representation of information about family relatives as structured data in electronic health records. Appl Clin Inform (2014) 0.81
Consistency of BRCA1 and BRCA2 Variant Classifications Among Clinical Diagnostic Laboratories. JCO Precis Oncol (2017) 0.80
Impact of familial risk factors on management and survival of early-onset breast cancer: a population-based study. Br J Cancer (2006) 0.80
Do people really know what makes a family history of cancer? Health Expect (2012) 0.80
Hormone replacement therapy, family history, and breast cancer risk among postmenopausal women. Epidemiology (2009) 0.80
Worry is good for breast cancer screening: a study of female relatives from the ontario site of the breast cancer family registry. J Cancer Epidemiol (2012) 0.80
The impact of in situ breast cancer and family history on risk of subsequent breast cancer events and mortality - a population-based study from Sweden. Breast Cancer Res (2016) 0.80
Cis-eQTL-based trans-ethnic meta-analysis reveals novel genes associated with breast cancer risk. PLoS Genet (2017) 0.79
Family history as a predictor for disease risk in healthy individuals: a cross-sectional study in Slovenia. PLoS One (2013) 0.79
Tumour morphology of early-onset breast cancers predicts breast cancer risk for first-degree relatives: the Australian Breast Cancer Family Registry. Breast Cancer Res (2012) 0.79
More breast cancer genes? Breast Cancer Res (2001) 0.79
Family history and risk of ductal carcinoma in situ and triple negative breast cancer in a Han Chinese population: a case-control study. World J Surg Oncol (2013) 0.79
Relationship between family history of breast cancer and clinicopathological features in Moroccan patients. Ethiop J Health Sci (2013) 0.79
Family history of breast cancer and its association with disease severity and mortality. Cancer Med (2016) 0.79
The association between metabolic health, obesity phenotype and the risk of breast cancer. Int J Cancer (2017) 0.79
Emerging Concepts in Breast Cancer Risk Prediction. Curr Obstet Gynecol Rep (2013) 0.78
Lifetime use of nonsteroidal anti-inflammatory drugs and breast cancer risk: results from a prospective study of women with a sister with breast cancer. BMC Cancer (2015) 0.78
A cross-sectional survey to estimate the prevalence of family history of colorectal, breast and ovarian cancer in a Scottish general practice population. Br J Cancer (2004) 0.78
Accuracy of Self-Reported Screening Mammography Use: Examining Recall among Female Relatives from the Ontario Site of the Breast Cancer Family Registry. ISRN Oncol (2013) 0.78
Familial risks and estrogen receptor-positive breast cancer in Hong Kong Chinese women. PLoS One (2015) 0.78
Towards personalized screening: Cumulative risk of breast cancer screening outcomes in women with and without a first-degree relative with a history of breast cancer. Int J Cancer (2015) 0.78
Obesity, diabetes mellitus, and the risk of female breast cancer in Eastern China. World J Surg Oncol (2013) 0.77
Inter-generational continuity in periodontal health: findings from the Dunedin family history study. J Clin Periodontol (2011) 0.77
Familial clustering of breast and prostate cancer and risk of postmenopausal breast cancer in the Women's Health Initiative Study. Cancer (2015) 0.77
Risk factors for breast cancer in China: similarities and differences with western populations. Arch Med Sci (2012) 0.76
The impact of cancer prevention guideline adherence on overall mortality in a high-risk cohort of women from the New York site of the Breast Cancer Family Registry. Breast Cancer Res Treat (2015) 0.76
A follow-up study of breast and other cancers in families of an unselected series of breast cancer patients. Br J Cancer (2002) 0.76
Predicting breast cancer risk: implications of a "weak" family history. Fam Cancer (2008) 0.76
Molecular tumor profiling: translating genomic insights into clinical advances. Genome Biol (2004) 0.76
Calibrated predictions for multivariate competing risks models. Lifetime Data Anal (2013) 0.76
Prospective study of high-risk, BRCA1/2-mutation negative women: the 'negative study'. BMC Cancer (2014) 0.76
Statistical methods in cancer research. Volume II--The design and analysis of cohort studies. IARC Sci Publ (1987) 27.11
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet (2003) 18.67
Statistical methods in cancer research. Volume I - The analysis of case-control studies. IARC Sci Publ (1980) 15.47
Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet (1998) 15.09
The Multicentre Aneurysm Screening Study (MASS) into the effect of abdominal aortic aneurysm screening on mortality in men: a randomised controlled trial. Lancet (2002) 10.52
Reduction of breast cancer mortality through mass screening with modern mammography. First results of the Nijmegen project, 1975-1981. Lancet (1984) 10.22
Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Lancet (1994) 9.60
Degenerate oligonucleotide-primed PCR: general amplification of target DNA by a single degenerate primer. Genomics (1992) 9.06
European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr (2002) 8.77
Survival of patients with breast cancer attending Bristol Cancer Help Centre. Lancet (1990) 7.04
Trends in mortality from cervical cancer in the Nordic countries: association with organised screening programmes. Lancet (1987) 6.91
Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer. J Natl Cancer Inst (1999) 6.48
Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst (1994) 6.27
What is the optimum interval between mammographic screening examinations? An analysis based on the latest results of the Swedish two-county breast cancer screening trial. Br J Cancer (1987) 6.20
Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS). Lancet (2005) 6.18
Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab (2001) 6.12
Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations. J Natl Cancer Inst (1998) 6.06
Evaluation of screening for breast cancer in a non-randomised study (the DOM project) by means of a case-control study. Lancet (1984) 5.87
The Swedish two county trial of mammographic screening for breast cancer: recent results and calculation of benefit. J Epidemiol Community Health (1989) 5.20
Disease susceptibility genes--their identification by multiple case family studies. Tissue Antigens (1976) 5.17
Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype-phenotype correlation. Nat Genet (1995) 4.86
Estimation of multiple relative risk functions in matched case-control studies. Am J Epidemiol (1978) 4.76
Simplified models of screening for chronic disease: estimation procedures from mass screening programmes. Biometrics (1984) 4.73
Monitoring the prevalence of HIV. BMJ (1989) 4.46
Involvement of Brca2 in DNA repair. Mol Cell (1998) 4.41
Update of the Swedish two-county program of mammographic screening for breast cancer. Radiol Clin North Am (1992) 4.34
Comparison of dietary assessment methods in nutritional epidemiology: weighed records v. 24 h recalls, food-frequency questionnaires and estimated-diet records. Br J Nutr (1994) 4.32
A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes. Br J Cancer (2002) 4.18
Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene. Nat Genet (1997) 4.16
Estimation of the duration of a pre-clinical disease state using screening data. Am J Epidemiol (1983) 4.11
The BOADICEA model of genetic susceptibility to breast and ovarian cancer. Br J Cancer (2004) 4.06
The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions. Br J Cancer (2008) 3.87
An evaluation of genetic heterogeneity in 145 breast-ovarian cancer families. Breast Cancer Linkage Consortium. Am J Hum Genet (1995) 3.81
Validation of dietary assessment methods in the UK arm of EPIC using weighed records, and 24-hour urinary nitrogen and potassium and serum vitamin C and carotenoids as biomarkers. Int J Epidemiol (1997) 3.79
Breast cancer treatment and natural history: new insights from results of screening. Lancet (1992) 3.77
Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt's lymphoma from Ugandan prospective study. Nature (1978) 3.73
Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence. Am J Hum Genet (1995) 3.71
Oral contraceptives and the risk of hereditary ovarian cancer. Hereditary Ovarian Cancer Clinical Study Group. N Engl J Med (1998) 3.60
Multistage models and primary prevention of cancer. J Natl Cancer Inst (1980) 3.55
Localization of the gene for Cowden disease to chromosome 10q22-23. Nat Genet (1996) 3.53
Polymorphisms associated with circulating sex hormone levels in postmenopausal women. J Natl Cancer Inst (2004) 3.53
Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population-based study. Genet Epidemiol (2001) 3.35
A clonal marker induced by mutation in mouse intestinal epithelium. Nature (1988) 3.35
Mutations of the RET proto-oncogene in Hirschsprung's disease. Nature (1994) 3.33
Dietary effects on breast-cancer risk in Singapore. Lancet (1991) 3.32
Population-based estimate of the average age-specific cumulative risk of breast cancer for a defined set of protein-truncating mutations in BRCA1 and BRCA2. Australian Breast Cancer Family Study. Cancer Epidemiol Biomarkers Prev (1999) 3.29
Allele losses in the region 17q12-21 in familial breast and ovarian cancer involve the wild-type chromosome. Nat Genet (1992) 3.13
How many more breast cancer predisposition genes are there? Breast Cancer Res (1999) 3.10
Cytogenetic analysis by chromosome painting using DOP-PCR amplified flow-sorted chromosomes. Genes Chromosomes Cancer (1992) 3.03
A case-control study of cervical cancer screening in north east Scotland. Br Med J (Clin Res Ed) (1985) 2.98
Development of the pattern of cell renewal in the crypt-villus unit of chimaeric mouse small intestine. Development (1988) 2.97
Oesophageal cancer studies in the Caspian Littoral of Iran: the Caspian cancer registry. Br J Cancer (1973) 2.93
Consistent loss of the wild type allele in breast cancers from a family linked to the BRCA2 gene on chromosome 13q12-13. Oncogene (1995) 2.91
The detection of gene-environment interaction for continuous traits: should we deal with measurement error by bigger studies or better measurement? Int J Epidemiol (2003) 2.89
Mutations truncating the EP300 acetylase in human cancers. Nat Genet (2000) 2.84
The impact of screening on the incidence of cervical cancer in England and Wales. Br J Obstet Gynaecol (1985) 2.83
Predicting the likelihood of carrying a BRCA1 or BRCA2 mutation: validation of BOADICEA, BRCAPRO, IBIS, Myriad and the Manchester scoring system using data from UK genetics clinics. J Med Genet (2008) 2.81
An analysis of variation in expression of neurofibromatosis (NF) type 1 (NF1): evidence for modifying genes. Am J Hum Genet (1993) 2.79
Risk models for familial ovarian and breast cancer. Genet Epidemiol (2000) 2.75
Models of genetic susceptibility to breast cancer. Oncogene (2006) 2.69
Television viewing and low participation in vigorous recreation are independently associated with obesity and markers of cardiovascular disease risk: EPIC-Norfolk population-based study. Eur J Clin Nutr (2003) 2.68
Scheduling of revaccination against hepatitis B virus. Lancet (1991) 2.65
Conservative treatment of mild/moderate cervical dyskaryosis: long-term outcome. Lancet (1992) 2.64
Indirect standardization and multiplicative models for rates, with reference to the age adjustment of cancer incidence and relative frequency data. J Chronic Dis (1975) 2.62
AIDS predictions. Lancet (1993) 2.56
DNA "fingerprints" and segregation analysis of multiple markers in human pedigrees. Am J Hum Genet (1986) 2.55
Familial breast cancer. BMJ (1994) 2.54
Mutation analysis of BRCA1 and BRCA2 in a male breast cancer population. Am J Hum Genet (1997) 2.53
DNA methylation patterns in hereditary human cancers mimic sporadic tumorigenesis. Hum Mol Genet (2001) 2.50
Treatment and survival in breast cancer in the Eastern Region of England. Ann Oncol (2009) 2.45
Instability of short tandem repeats (microsatellites) in human cancers. Nat Genet (1994) 2.45
High prevalence of the 999del5 mutation in icelandic breast and ovarian cancer patients. Cancer Res (1996) 2.43
A systematic review of genetic polymorphisms and breast cancer risk. Cancer Epidemiol Biomarkers Prev (1999) 2.39
Familial gastric cancer: overview and guidelines for management. J Med Genet (1999) 2.38
Somatic mutations in the p53 gene and prognosis in breast cancer: a meta-analysis. Br J Cancer (1999) 2.36
The design of case-control studies: the influence of confounding and interaction effects. Int J Epidemiol (1984) 2.35
Derivation of mouse intestinal crypts from single progenitor cells. Nature (1985) 2.31
Diagnostic accuracy of faecal occult blood tests used in screening for colorectal cancer: a systematic review. J Med Screen (2007) 2.30
Polygenic susceptibility to prostate and breast cancer: implications for personalised screening. Br J Cancer (2011) 2.28
A case-control study of oesophageal adenocarcinoma in women: a preventable disease. Br J Cancer (2000) 2.27
Deletion of genes on chromosome 1 in endocrine neoplasia. Nature (1987) 2.27
Localization to Xq27 of a susceptibility gene for testicular germ-cell tumours. Nat Genet (2000) 2.26
Leukemia following Hodgkin's disease. N Engl J Med (1990) 2.25
The relative contributions of screen-detected in situ and invasive breast carcinomas in reducing mortality from the disease. Eur J Cancer (2003) 2.24
Nutritional methods in the European Prospective Investigation of Cancer in Norfolk. Public Health Nutr (2001) 2.21
Recognition and initial management of ovarian cancer: summary of NICE guidance. BMJ (2011) 2.21
Undiagnosed glucose intolerance in the community: the Isle of Ely Diabetes Project. Diabet Med (1995) 2.20
Identification of germ-line E-cadherin mutations in gastric cancer families of European origin. Cancer Res (1998) 2.20
Discovering carcinogens in the occupational environment: a novel epidemiologic approach. J Natl Cancer Inst (1981) 2.18
Height and glucose tolerance in adult subjects. Diabetologia (1991) 2.17
Fasting proinsulin concentrations predict the development of type 2 diabetes. Diabetes Care (1999) 2.16
A linked genetic marker for multiple endocrine neoplasia type 2A on chromosome 10. Nature (1987) 2.15